Literature DB >> 14520691

Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines.

Bastiaan P van Rees1, Anna Sivula, Staffan Thorén, Hiroshi Yokozaki, Per-Johan Jakobsson, G Johan A Offerhaus, Ari Ristimäki.   

Abstract

Gastrointestinal carcinomas synthesize elevated levels of prostaglandin E(2) (PGE(2)), which has been mechanistically linked to carcinogenesis. Recently, microsomal prostaglandin E synthase-1 (mPGES-1) was cloned, which seems to be inducible and linked to cyclooxygenase-2 (Cox-2) in the biosynthesis of PGE(2). We examined expression of mPGES-1 in intestinal type gastric adenocarcinomas and in gastric cancer cell lines. The transcript for mPGES-1 was elevated in 57% (4/7) of gastric carcinomas as detected by Northern blot analysis. Moderate to strong mPGES-1 immunoreactivity was observed in 56% (5/9) of the carcinomas as detected by immunohistochemistry. Furthermore, mPGES-1 mRNA, protein and microsomal PGES activity were detected in gastric adenocarcinoma cell lines that originated from intestinal type tumors (MKN-7 and MKN-28). In contrast to Cox-2, however, expression of mPGES-1 mRNA or protein were not induced by phorbol 12-myristate 13-acetate (PMA) or interleukin-1beta (IL-1beta) in any of the gastric cancer cell lines tested (MKN-1, -7, -28, -45 and -74). Two gastric cancer cell lines (MKN-45 and MKN-74) did not express mPGES-1 and lacked microsomal PGES activity, but were still able to synthesize PGE(2). Because all gastric cell lines expressed cPGES as detected by immunoblotting, it is possible that Cox-2 can interact with cPGES or with some other yet unidentified PGES in gastric cancer cells. Furthermore, our data show that regulatory mechanisms that drive expression of mPGES-1 and Cox-2 dissociate in gastric cancer cell lines. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520691     DOI: 10.1002/ijc.11422

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers.

Authors:  Hui-Hua Chang; Zuohe Song; Lee Wisner; Tina Tripp; Vijay Gokhale; Emmanuelle J Meuillet
Journal:  Invest New Drugs       Date:  2011-09-20       Impact factor: 3.850

2.  NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells.

Authors:  Xiaoxu Zhou; Dan Li; Murray B Resnick; Jack Wands; Weibiao Cao
Journal:  Mol Pharmacol       Date:  2013-02-25       Impact factor: 4.436

Review 3.  The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models.

Authors:  Hiroko Oshima; Masanobu Oshima
Journal:  J Gastroenterol       Date:  2012-01-05       Impact factor: 7.527

4.  The role of PGE2-associated inflammatory responses in gastric cancer development.

Authors:  Hiroko Oshima; Masanobu Oshima
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

5.  Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis.

Authors:  Louise R Howe; Kotha Subbaramaiah; Claire V Kent; Xi K Zhou; Sung-Hee Chang; Timothy Hla; Per-Johan Jakobsson; Clifford A Hudis; Andrew J Dannenberg
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-04-25       Impact factor: 3.072

6.  Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts.

Authors:  Tove Båge; Johan Lindberg; Joakim Lundeberg; Thomas Modéer; Tülay Yucel-Lindberg
Journal:  BMC Genomics       Date:  2010-04-15       Impact factor: 3.969

Review 7.  Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.

Authors:  Jessica K Norberg; Earlphia Sells; Hui-Hua Chang; Srinivas R Alla; Shuxing Zhang; Emmanuelle J Meuillet
Journal:  Pharm Pat Anal       Date:  2013-03

8.  Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.

Authors:  Linda M Dong; Xiao-Ou Shu; Yu-Tang Gao; Ginger Milne; Bu-Tian Ji; Gong Yang; Hong-Lan Li; Nathaniel Rothman; Wei Zheng; Wong-Ho Chow; Christian C Abnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

9.  Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis.

Authors:  Tae Jung Jang
Journal:  Virchows Arch       Date:  2004-09-14       Impact factor: 4.064

Review 10.  Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond.

Authors:  Shu Xu; Carol A Rouzer; Lawrence J Marnett
Journal:  IUBMB Life       Date:  2014-12-23       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.